BioinksBioprintingCellular Agriculture

Jellatech showcases cell-based collagen bioink

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

North Carolina-based biotech startup Jellatech reached a major milestone with the production of cell-based collagen. Only 2 years since it was founded, Jellatech successfully developed of a full-length, triple helical and functional collagen made from their own proprietary cell lines.

“This is a major milestone for us and I am beyond proud and excited that we are already here. Being able to see our clean cell-based collagen with the naked eye – it brings happy tears.” -Stephanie Michelsen, CEO

Collagen is one of the most unique and abundant proteins in mammals. The triple-helical protein provides structure to cells and tissue. Collagen is widely used across industries making up a $8.4Bn market including biomedical, health, personal care & beauty, materials and food & beverage industry applications. However, the protein is only found in animals. With an increasing demand for sustainability as well as supply chain challenges, many companies are desperately looking for novel sources for collagen. This is where Jellatech sees itself as the answer.

Jellatech successfully developed of a full-length, triple helical and functional cell-based collagen made from proprietary cell lines. 
​“We’re thrilled to see that our cell-derived collagen appears bio-identical to collagen derived from animals. Because of this, we have a wide range of exciting applications from biomedicine to cosmetics to food and beverage,” commented Rob Schutte, Head of Science

Jellatech is not the only company with sustainable collagen in sight, as a few other biotech startups are also eyeing the lucrative collagen market. Cell-based collagen can have a few advantages. With fermentation and plant-based collagen, as well as other similar technologies, applications are more limited as these technologies are unable to provide the same function due to the fact they are not bio-identical to that of animal-derived collagen. This is the problem Jellatech has been able to solve through its cell-based collagen technology.

“Collagen formation is a complex process that requires specialized machinery found only in mammalian cells.  We’re working to harness the innate ability of these cells to produce collagen that is bio-identical to native collagen and do it in a sustainable and animal-free way.” concluded Christopher Gilchrist, Senior Scientist

Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...


VoxelMatters is the online trade media portal published by 3dpbm, a leading marketing and market research firm specializing in the AM industry. 3dpbm also publishes the 3D Printing Business Directory, the AM Focus eBook series and the 3dpbm Research AM Market Reports. 3D Printing Media Network was founded with the goal to provide the latest industry news, insights and opinions to a global audience of professionals and decision makers.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.